Skip to main content

Elanco’s $1.6 billion IPO looks too pricey, and here’s why

Traditional metrics obscure an expensive valuation for this Eli Lilly spinoff.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.